| Detected | Trial | Change |
|---|---|---|
| 2026-08-05 | NCT07586280 VR for Cataract Anxiety Lowering Management |
Completed without a posted recruiting period |
| 2026-08-05 | NCT07586280 VR for Cataract Anxiety Lowering Management |
date change Primary completion moved earlier: 2026-08-30 -> 2026-06-30 |
| 2026-08-05 | NCT07586280 VR for Cataract Anxiety Lowering Management |
date change Completion moved earlier: 2026-09-30 -> 2026-06-30 |
| 2026-08-05 | NCT07620821 VR for Cataract Anxiety Lowering Management--A RCT Study |
Completed without a posted recruiting period |
| 2026-08-05 | NCT07620821 VR for Cataract Anxiety Lowering Management--A RCT Study |
Enrollment reduced: 260 -> 223 participants |
| 2026-08-05 | NCT07620821 VR for Cataract Anxiety Lowering Management--A RCT Study |
date change Primary completion moved earlier: 2026-08-30 -> 2026-07-30 |
| 2026-08-05 | NCT07620821 VR for Cataract Anxiety Lowering Management--A RCT Study |
date change Completion moved earlier: 2026-09-30 -> 2026-07-30 |
| 2026-08-02 | NCT06509945 Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL |
overall status: Recruiting → Unknown |
| 2026-07-22 | NCT07713823 Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer… |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07713823 Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06568445 | Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy | Bronchial Asthma | Not Yet Recruiting |
| NCT07365371 | A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the… | Polypoidal Choroidal Vasculopathy (PCV) | Not Yet Recruiting |
| NCT07557394 | A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui… | Pancreatic Cancer | Not Yet Recruiting |
| NCT07637968 | Tegileridine vs Sufentanil for Postoperative Pain Management and Gastrointestinal… | Postoperative Pain | Not Yet Recruiting |
| NCT07675252 | Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases… | Acute Wheezing Disorders in Infants Aged 0 to 24 Months | Not Yet Recruiting |
| Phase 3 | |||
| NCT07414758 | Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response… | Peripheral T Cell Lymphoma | Recruiting |
| NCT07469046 | VAH vs VA in Newly Diagnosed Elderly AML | Acute Myeloid Leukemia (AML) | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07389616 | A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression… | Peripheral T Cell Lymphoma | Recruiting |
| NCT07463313 | 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced… | Thymoma and Thymic Carcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT05536102 | The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric… | Gastric Cancer | Recruiting |
| NCT05841771 | Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid… | Hypomethylating Agent | Recruiting |
| NCT06598722 | BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic… | Lymphoblastic Lymphoma, Adult | Recruiting |
| NCT06612944 | Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very… | Myelodysplastic Syndromes, Adult | Recruiting |
| NCT06686108 | Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06532617 | Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced… | Pancreatic Neoplasms | Recruiting |
| NCT06483906 | Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for… | Acute Myeloid Leukemia | Recruiting |
| NCT06832774 | Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment… | Prostate Cancer Metastatic Disease | Recruiting |
| NCT07570745 | Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous… | Graft-Versus-Host Disease(GVHD) | Recruiting |
| NCT07601737 | Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally… | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06614348 | Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery | Age Related Cataract | Not Yet Recruiting |
| NCT06623513 | Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis | Pancreatitis, Acute | Not Yet Recruiting |
| NCT06754540 | Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia… | Acute Myeloid Leukemia (AML) | Not Yet Recruiting |
| NCT07142863 | Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable… | Osteosarcoma | Not Yet Recruiting |
| NCT07236645 | Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy (NPDR) | Not Yet Recruiting |
| NCT07276698 | Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After… | NK T-Cell Lymphoma | Not Yet Recruiting |